Relationship between Elevated Liver enzymes and Metabolic syndrome among Egyptian adults

Salama, Rasha I; Emara, Mohamed H; Eldeep, Ahmed A

doi:10.21608/aeji.2019.12382.1021

	Relationship between Elevated Liver enzymes and Metabolic syndrome among Egyptian adults
Afro-Egyptian Journal of Infectious and Endemic Diseases
Article 2, Volume 9, Issue 3, September 2019, Page 199-206 PDF (335.18 K)
Document Type: Original Article
DOI: 10.21608/aeji.2019.12382.1021
View on SCiNiTO
Authors
Rasha I Salama ¹; Mohamed H Emara ²; Ahmed A Eldeep³
¹Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
²Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Kafrelshiekh University, Kafr Elshiekh, Egypt.
³Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Abstract
Background and study aim: Liver enzymes are important markers for hepatocyte damage. Metabolic syndrome (MS) is a combination of metabolic abnormalities including high blood glucose, obesity, hypertension and dyslipidemia. The incidence of MS is believed to be increasing in Egypt. The purpose of this study is to examine the relationship between elevated liver enzymes and MS among Egyptian adults. Patients and Methods: A total 138 apparently healthy subjects were randomly included (99 females and 39 males). Demographic, clinical (blood pressure, body mass index and waist circumference) and biochemical (measurements of alanine aminotransferase (ALT), aspartate amino-transferase (AST), alkaline phosphatase (ALP), lipid profile, blood glucose and viral markers) were collected from every subject. Metabolic syndrome was defined according to a well-known criteria and subjects in the final analysis were divided into group I; metabolic syndrome and group II; non-metabolic syndrome subjects. Results: In this study, 92 persons fulfilled three of the five criteria of metabolic syndrome (group I) with prevalence of 66.7% while group II (non-metabolic syndrome) represented 33.3%. Patients with MS were older and less physically active in comparison with group II. There were an association between elevations in liver enzymes (ALT, AST, ALP) and MS. ALT, AST and ALP were elevated in 42.4%, 17.2% and 20.7% of patients with MS respectively. ALT and AST showed positive correlation with elevated blood glucose and triglycerides levels while AST/ALT ratio showed negative correlation with diastolic blood pressure, triglycerides level and waist circumference. The more items of MS the patient have the higher the level of liver enzymes. Conclusion: Among Egyptian adults elevated levels of liver enzymes were associated with MS and a correlation was noticed with its components.
Keywords
ALT; AST; ALP; Metabolic syndrome


Statistics Article View: 477 PDF Download: 542